Castration Sensitive Prostate Cancer Clinical Trials

6 clinical trials for Castration Sensitive Prostate Cancer across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC) — RECRUITING · PHASE2
• A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy — RECRUITING · PHASE1
• Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy — RECRUITING · PHASE4
• Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy Delivery — NOT_YET_RECRUITING · PHASE1
• Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial — NOT_YET_RECRUITING · PHASE2
• Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment — NOT_YET_RECRUITING · PHASE2

Refine this search